Introduction
Castleman's disease (in the literature also known as angiofollicular hyperplasia) is a rare benign lymphoproliferative disease. Clinically, it can manifest as unicentric (UCD) or multicentric (MCD) Castelman's disease. The number of people diagnosed with Castelman's disease each year is not well known, but it is estimated that there are approximately 6500 to 7700 new cases per year in the US 1 . The estimated US 10-year prevalence of MCD was 2.4 per million 2 . The pathogenesis of the disease is not fully understood. Overproduction of interleukin-6 (IL-6) in UCD and both IL-6 and infection with human herpes virus 8 (HHV-8) in MCD have been described as the main etiologic factors 3, 4 . Deregulated and overproduced IL-6, particularly in patients with MCD, stimulates the production of acute phase reactants in the liver, resulting in constitutional symptoms including fever, sweats and fatigue, and laboratory anomalies such as anemia, elevated inflammatory markers, hypergammaglobulinemia and hypoalbuminemia
5
. IL-6 also stimulates Bcell proliferation and survival. Additionally, it induces the expression of vascular endothelial growth factor and increased angiogenesis 5 . HIV-associated MCD is uniformly associated with HHV-8 infection, although its prevalence in HIV-negative MCD varies by the local prevalence rate of HHV-8. Plasma levels of HHV-8 DNA correlate with clinical symptoms and predict relapse rates in HIV-associated MCD 6 . In patients with HHV-8 positive MCD, HHV-8 infected vascular and lymphoid cells express viral analog of IL-6 (vIL-6) thus contributing to the pathogenesis.
Diagnosis of the disease is made by excisional biopsy of affected lymph node tissue. In cases of deeper and less accessible disease, core needle biopsy is preferred over fine needle aspiration, since fine needle aspiration . It usually progresses without symptoms and is characterized by a relatively large, i.e. bulky, slowly growing tumorous mass. UCD is most often diagnosed by accident or by symptomatology resulting from compression upon the adjoining anatomical structures. Considering its lymphatic origin, tumor mass can theoretically occur in any body region. However, the most common localization is mediastinum, more specifically anterior mediastinum, right paratracheal, lung hilum and posterior mediastinum 3 . The patient may sometimes experience nonspecific disturbances similar to B symptoms such as weight loss, loss of appetite, night sweats, fever that is sometimes accompanied by increased erythrocyte sedimentation rate, increase of serum C-reactive protein concentration and polyclonal gammopathy on serum protein electrophoresis. All these symptoms are the result of increased IL-6 production, and are almost exclusively associated with the plasmacellular histologic subtype 3, 8 . Therapy of choice for unicentric form of the disease is total surgical excision of the tumor with very low incidence of relapse 8, 9 . For the disease that cannot be completely excised, radiation therapy is recommended 10, 11 . In selected patients who are not candidates for surgical resection or radiotherapy, partial resection or clinical observation alone can be sufficient. However, if the disease becomes symptomatic, systemic treatment should be considered 5 . Multicentric Castleman's disease is more typical in older patients (6 th decade of life) or in HIV positive patients regardless of age 3, 10 . HIV infection is an important risk factor for MCD, and all patients with HIV-associated MCD are coinfected with HHV-8 5 . Systemic inflammatory manifestations similar to B symptoms (fever, night sweats, weight loss and fatigue) characterize the vast majority of MCD patients. The usual findings during physical examination are general lymphadenopathy, hepatosplenomegaly, with many patients presenting with fluid retention (lower extremity edema, pleural or pericardial effusions, or ascites). Common hematologic abnormalities include anemia, elevated inflammatory markers (erythrocyte sedimentation rate and C-reactive protein), hypergammaglobulinemia and hypoalbuminemia. The presentation of the disease can vary ranging from indolent or slow progressing to acute and fulminant. Some patients may experience relapsing-remitting course of the disease 5, 12 . In case of concomitant infection with HIV and HHV-8, additional symptomatology is possible (low T-cell CD4 count, opportunistic infections, occurrence of Kaposi sarcoma or primary effusion lymphoma, etc.). The recommended treatment of choice is systemic monotherapy with the anti-CD20 monoclonal antibody rituximab [12] [13] [14] [15] . Therapy with glucocorticoids offers short-term control of the symptoms, however, complete remissions are rare and shortlived 3, 16 . In patients with coinfection with HIV and/or HHV-8, antiretroviral therapy together with antiviral therapy (valgancyclovir or gancyclovir) should also be initiated. As second-line treatment in HIV negative patients, the anti-IL-6 monoclonal antibody siltuximab is recommended 5 . Further lines of treatment involve administration of single-agent or combination of chemotherapeutics (etoposide, vinblastine or liposomal doxorubicin). Currently, there are clinical trials investigating therapy with siltuximab and tocilizumab in HIV positive MCD 5 .
Case Report
A previously healthy 24-year-old woman was observed at Surgical Emergency Unit of the Split University Hospital Center because of protracted back pain that occurred 2 days earlier when she suffered a traffic accident. As part of diagnostic workup, chest radiography was performed. It showed a suspect tumorous mass localized in the anterior mediastinum. Urgent investigation was further extended by multislice computed tomography imaging (MSCT) of the thorax and transthoracic echocardiography that raised suspicion of left ventricle pseudoaneurysm (Fig. 1) . The patient was hospitalized at the Department of Cardiology, Split University Hospital Center. Using MSCT angiography, the mass was characterized as a well vascularized, irregular, expansive tumor localized adjacent to the left ventricle, measuring 3x6.3 cm in diameter. Thus, the diagnosis of left ventricle pseudoaneurysm was excluded and the mass showed properties similar to hemangioma. Imaging analysis
was further extended by digital subtraction angiography (DSA), which also showed exceptional vascularization of the tumor (Fig. 2) . Cranial portion of the tumor was irrigated from the left internal thoracic artery (mammary artery), while caudal portion received arterial supply from celiac trunk. Venous branches were part of the left brachiocephalic trunk basin. By using magnetic resonance imaging of the heart, the neoplasm was visualized as a solid mass with smooth contours, very well imbibed and vascularized, without signs of myocardial and/or pericardial invasion (Fig.  3) . Finally, the early diagnosis of hemangioma was established and the cardiology-cardiac surgery team made a decision to perform full excision of the tumor. The operation was performed successfully and without further complications (Fig. 4) . Histopathologic analysis of the tumor showed the lymph node tissue that had features characteristic of the hyaline-vascular type of Castleman's disease (Fig. 5) . Currently, the patient undergoes regular medical check-ups and she is without any symptoms and signs of relapse of the disease.
Conclusion
Castleman's disease is a very rare entity and thus there is a scarce number of epidemiological studies. Mediastinal localization has been presented in the majority of published cases. However, paracardiac localization has not been described previously. In this clinical case, specific localization of the tumor and its radiological properties can pose a differential diagnostic dilemma and can clinically impose as (pseudo) aneurysm of the left ventricle or hemangioma. Therefore, correct diagnosis is only possible after complete surgical excision and histopathologic analysis, which in this case is the optimal therapeutic approach.
